{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:36:11Z","timestamp":1792146971517,"version":"4.4.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/mph.0b013e3181923cb4","type":"journal-article","created":{"date-parts":[[2009,1,30]],"date-time":"2009-01-30T03:15:47Z","timestamp":1233285347000},"page":"81-84","source":"Crossref","is-referenced-by-count":47,"title":["Experience With Hemophagocytic Lymphohistiocytosis\/Macrophage Activation Syndrome at a Single Institution"],"prefix":"10.1097","volume":"31","author":[{"given":"Abha A.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim","family":"Valani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdelhaleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Weitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210312","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C","article-title":"Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic\/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society","volume":"29","author":"Favara","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"R2-1-20210312","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"R3-1-20210312","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"R4-1-20210312","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R5-1-20210312","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R6-1-20210312","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"R7-1-20210312","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2007.05.001","article-title":"Hemophagocytic syndromes","volume":"21","author":"Janka","year":"2007","journal-title":"Blood Rev"},{"key":"R8-1-20210312","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"key":"R9-1-20210312","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(85)80072-X","article-title":"Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection","volume":"106","author":"Hadchouel","year":"1985","journal-title":"J Pediatr"},{"key":"R10-1-20210312","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R11-1-20210312","first-page":"380","article-title":"Histocytic Disorders of Children and Adults","author":"Ramanan","year":"2005"},{"key":"R12-1-20210312","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","article-title":"Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients","volume":"40","author":"Stephan","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"R13-1-20210312","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1182\/blood.V86.12.4706.bloodjournal86124706","article-title":"Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis","volume":"86","author":"Imashuku","year":"1995","journal-title":"Blood"},{"key":"R14-1-20210312","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","article-title":"Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"7","author":"Villanueva","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"R15-1-20210312","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/rheumatology\/keg074","article-title":"Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation","volume":"42","author":"Wulffraat","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R16-1-20210312","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2006-04-015693","article-title":"Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease","volume":"108","author":"Marcenaro","year":"2006","journal-title":"Blood"},{"key":"R17-1-20210312","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2001.19.10.2665","article-title":"Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"19","author":"Imashuku","year":"2001","journal-title":"J Clin Oncol"},{"key":"R18-1-20210312","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00443367","article-title":"Familial hemophagocytic lymphohistiocytosis","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr"},{"key":"R19-1-20210312","first-page":"197","article-title":"Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society","volume":"10","author":"Arico","year":"1996","journal-title":"Leukemia"},{"key":"R20-1-20210312","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/10428190009148855","article-title":"Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis","volume":"36","author":"Imashuku","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"R21-1-20210312","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","article-title":"Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia","volume":"325","author":"Pui","year":"1991","journal-title":"N Engl J Med"},{"key":"R22-1-20210312","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/08880019309016551","article-title":"Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis","volume":"10","author":"Henter","year":"1993","journal-title":"Pediatr Hematol Oncol"},{"key":"R23-1-20210312","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mpo.1189","article-title":"Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"37","author":"Kitazawa","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R24-1-20210312","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.20462","article-title":"Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis","volume":"81","author":"Henzan","year":"2006","journal-title":"Am J Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181923cb4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:33:15Z","timestamp":1786037595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200902000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181923cb4","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}